Standard BioTools (LAB) Competitors $1.33 +0.05 (+3.91%) Closing price 09/11/2025 04:00 PM EasternExtended Trading$1.37 +0.04 (+3.01%) As of 04:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LAB vs. TXG, EYPT, TRNS, ALNT, AEHR, CTKB, SENS, FEIM, QSI, and MASSShould you be buying Standard BioTools stock or one of its competitors? The main competitors of Standard BioTools include 10x Genomics (TXG), Eyepoint Pharmaceuticals (EYPT), Transcat (TRNS), Allient (ALNT), Aehr Test Systems (AEHR), Cytek Biosciences (CTKB), Senseonics (SENS), Frequency Electronics (FEIM), Quantum-Si (QSI), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry. Standard BioTools vs. Its Competitors 10x Genomics Eyepoint Pharmaceuticals Transcat Allient Aehr Test Systems Cytek Biosciences Senseonics Frequency Electronics Quantum-Si 908 Devices Standard BioTools (NASDAQ:LAB) and 10x Genomics (NASDAQ:TXG) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations. Which has higher earnings & valuation, LAB or TXG? Standard BioTools has higher earnings, but lower revenue than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStandard BioTools$174.43M2.91-$138.88M-$0.32-4.1610x Genomics$610.78M2.66-$182.63M-$0.70-18.66 Does the media prefer LAB or TXG? In the previous week, 10x Genomics had 10 more articles in the media than Standard BioTools. MarketBeat recorded 15 mentions for 10x Genomics and 5 mentions for Standard BioTools. Standard BioTools' average media sentiment score of 1.90 beat 10x Genomics' score of 0.86 indicating that Standard BioTools is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Standard BioTools 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive 10x Genomics 5 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, LAB or TXG? Standard BioTools has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Comparatively, 10x Genomics has a beta of 2, indicating that its share price is 100% more volatile than the S&P 500. Do analysts rate LAB or TXG? Standard BioTools presently has a consensus price target of $1.55, suggesting a potential upside of 16.54%. 10x Genomics has a consensus price target of $13.65, suggesting a potential upside of 4.55%. Given Standard BioTools' higher possible upside, equities research analysts plainly believe Standard BioTools is more favorable than 10x Genomics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Standard BioTools 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.0010x Genomics 1 Sell rating(s) 8 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.33 Do institutionals & insiders hold more shares of LAB or TXG? 53.7% of Standard BioTools shares are held by institutional investors. Comparatively, 84.7% of 10x Genomics shares are held by institutional investors. 23.2% of Standard BioTools shares are held by insiders. Comparatively, 9.4% of 10x Genomics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is LAB or TXG more profitable? 10x Genomics has a net margin of -13.13% compared to Standard BioTools' net margin of -69.08%. 10x Genomics' return on equity of -12.88% beat Standard BioTools' return on equity.Company Net Margins Return on Equity Return on Assets Standard BioTools-69.08% -20.23% -15.32% 10x Genomics -13.13%-12.88%-10.03% Summary10x Genomics beats Standard BioTools on 9 of the 16 factors compared between the two stocks. Get Standard BioTools News Delivered to You Automatically Sign up to receive the latest news and ratings for LAB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LAB vs. The Competition Export to ExcelMetricStandard BioToolsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$488.95M$2.09B$5.78B$10.07BDividend YieldN/AN/A5.69%4.62%P/E Ratio-4.1635.9374.9726.20Price / Sales2.9110.59472.3091.87Price / CashN/A56.3537.0859.91Price / Book1.0511.8912.116.28Net Income-$138.88M-$63.67M$3.29B$270.85M7 Day Performance2.31%1.95%1.55%3.58%1 Month Performance1.53%7.60%7.83%6.67%1 Year Performance-34.48%38.37%61.70%27.73% Standard BioTools Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABStandard BioTools2.7802 of 5 stars$1.33+3.9%$1.55+16.5%-32.8%$488.95M$174.43M-4.16620Positive NewsInsider TradeTXG10x Genomics3.4018 of 5 stars$14.01-1.9%$13.54-3.3%-40.9%$1.74B$610.78M-20.011,240News CoverageAnalyst ForecastEYPTEyepoint Pharmaceuticals2.106 of 5 stars$11.57-0.3%$26.86+132.1%+62.2%$797.49M$43.27M-4.32120Positive NewsTRNSTranscat3.866 of 5 stars$83.95-0.6%$112.20+33.7%-36.2%$782.34M$278.42M58.711,245News CoveragePositive NewsShort Interest ↑ALNTAllient2.9926 of 5 stars$45.38-4.1%$35.00-22.9%+146.4%$769.05M$529.97M52.772,525Positive NewsAEHRAehr Test Systems2.3253 of 5 stars$24.95-7.8%N/A+104.7%$746.38M$58.97M-191.9190Positive NewsCTKBCytek Biosciences2.0719 of 5 stars$4.14-0.7%$5.60+35.3%-24.8%$526.71M$200.45M-82.80500Positive NewsSENSSenseonics2.2813 of 5 stars$0.46-0.1%$1.54+234.6%+15.6%$374.35M$25.47M-3.5390FEIMFrequency Electronics1.5256 of 5 stars$32.25-1.7%N/A+172.4%$314.41M$69.81M13.06200News CoverageEarnings ReportQSIQuantum-Si2.8111 of 5 stars$1.12-2.6%$3.48+210.3%+30.4%$226.79M$3.06M-1.65150News CoveragePositive NewsAnalyst ForecastMASS908 Devices3.4307 of 5 stars$6.25-0.2%$8.00+28.0%+63.9%$224.13M$59.63M-11.5760Positive News Related Companies and Tools Related Companies 10x Genomics Alternatives Eyepoint Pharmaceuticals Alternatives Transcat Alternatives Allient Alternatives Aehr Test Systems Alternatives Cytek Biosciences Alternatives Senseonics Alternatives Frequency Electronics Alternatives Quantum-Si Alternatives 908 Devices Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LAB) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Standard BioTools Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Standard BioTools With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
